Primary source AseBio: BIOSPAIN 2026 convertirá Bilbao en el epicentro europeo del debate sobre el futuro de la biotecnología

BioSpain 2026, Spain’s largest biotech meeting, runs from 29 September to 1 October at the Bilbao Exhibition Centre, organised by AseBio with the Diputación Foral de Bizkaia, the Basque Government and the Basque Health Cluster. Ahead of it, AseBio has published the sector’s figures and its agenda. Five movements for a manufacturing reader, all from texts published by AseBio.
1. The event
The programme has four tracks (Policy, Health, Bioeconomy, Finance) and the United Kingdom is guest nation. AseBio says the 2026 edition will also discuss how to drive advanced manufacturing. The 2025 edition in Barcelona drew more than 2,400 attendees from 35 countries, 140 investors from 76 entities and more than 4,500 business meetings. AseBio, 21 Jul 2026.
2. The sector in numbers
| Indicator | Figure | Year |
|---|---|---|
| Biotech companies | more than 1,100 (+10.4%) | latest AseBio data |
| Economic impact | 1.2% of GDP | latest AseBio data |
| R&D investment by biotech companies | 1,460 M EUR (+14%), 6% of national R&D | 2024 |
| Capital raised | 408 M EUR (+125%), 302 M EUR in deals with international investors | 2025 |
| Alliances signed | 266 | 2025 |
| Sector revenue | more than 13,000 M EUR | 2023 |
Sources: column by SID’s co-CEO, 22 Sep 2026 and column by AseBio’s president, 25 Sep 2026. Except 2023 revenue, the figures also appear in AseBio’s release of 10 Jun 2026.
3. Biotech Act II and an industrial capacity study
On 30 September AseBio hosts a session on the future Biotech Act II, focused on scaling biotech innovation, biomanufacturing and value chains, with speakers from Spain’s Ministry of Industry, the European Commission’s DG GROW and IFF. AseBio says it will present the main conclusions of its study on industrial capacities in Spain there, including financing for first industrial plants. A Biotech Act I session is scheduled for 29 September. AseBio, 15 Sep 2026.
4. The host region
According to the latest AseBio report, the Basque Country has 108 biotech companies, close to 10% of the national total. Bizkaia accounts for 45% of the region’s sector companies, 44% of its employment and 56% of its revenue. AseBio lists biomanufacturing among the region’s strengths. AseBio, 21 Jul 2026.
5. Public funding and a CDMO view
On 14 September the Science Ministry, through CDTI, added 100 M EUR to its 2026 calls: NEOTEC doubles from 20 to 40 M EUR and Misiones Ciencia e Innovación grows from 60 to 140 M EUR. The extra money targets dual-use, security or defence projects. AseBio, 22 Sep 2026. In a BioSpain column, 3PBIOVIAN’s Chief Commercial Officer argues that manufacturing should not be treated as a stage after innovation; the Pamplona site turns 20 in 2027. AseBio, 24 Sep 2026.
What it means for a plant
Spain’s published numbers are about companies, R&D and funding. None of these texts gives installed manufacturing capacity: no litres, no plant count, no scale. The industrial capacity study whose conclusions AseBio will present on 30 September is the first place such data could appear. If the study is published, we will read it in full.
Sources
- AseBio, BIOSPAIN 2026 convertirá Bilbao en el epicentro europeo del debate sobre el futuro de la biotecnología, 21 Jul 2026.
- AseBio, AseBio lleva a BIOSPAIN 2026 el debate sobre las claves de la Biotech Act, 15 Sep 2026.
- AseBio (column by Pilar Gil, SID), Crecer, conectar e innovar: el siguiente paso de la biotecnología española, 22 Sep 2026.
- AseBio (column by Cristina Nadal, AseBio), España y Europa ante la oportunidad de convertirse en una potencia biotecnológica, 25 Sep 2026.
- AseBio, El MICIU amplía en 100 millones de euros el presupuesto de NEOTEC y Misiones Ciencia e Innovación 2026, 22 Sep 2026.
- AseBio (column by Elena Erroba, 3PBIOVIAN), Construir una compañía biotecnológica de éxito, 24 Sep 2026.
- AseBio, El sector biotech marca récord histórico de captación de inversión, 10 Jun 2026.

